BARDA has a proven track record of responding to pandemics and developing lifesaving medical countermeasures. We are rapidly executing new partnerships and building a robust COVID-19 MCM Portfolio because Americans deserve to have safe, effective medical products.
Be the first to get updated on the progress of BARDA Portfolio Partners. Sign-up for our email announcements:
- Rapidly Deployable Capabilities
BARDA'S Impact of Diagnostic Investments
Rapidly deploying test kits to Americans